Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.71ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.71NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.12.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.12.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.12.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.12.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DN.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DN.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.51ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.51NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XRORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XRENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XRENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XRNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.350.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.350.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.350.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.350.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.254ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.254ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.254ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.254NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.39.1.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.39.1.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.39.1.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.1.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.418ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.418ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.418ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.418NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.9.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.9.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used